Phibro Animal Health | PAHC - 贷款资金

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.34B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	贷款资金	更改		日
Align Technology	USD 0		0	2024-12
ANI Pharmaceuticals	USD 286M		5.84M	2026-03
Aurora Cannabis	CAD 18.13M		15.07M	2026-03
Bristol-Myers Squibb	USD 42.15B		698M	2026-03
Canopy Growth	CAD 217.12M		7.87M	2026-03
Eli Lilly	USD 39.37B		1.5B	2026-03
Henry Schein	USD 2.33B		17M	2026-03
Idexx Laboratories	USD 299.85M		74.99M	2026-03
Knight Therapeutics	CAD 57.78M		26.92M	2025-12
Merck	USD 46.67B		77M	2026-03
Nektar Therapeutics	USD 63.16M		44.35M	2025-12
Pacira	USD 367.66M		4.53M	2026-03
Phibro Animal Health	USD 597.68M		5.92M	2026-03
Prestige Brands	USD 1.01B		40.28M	2026-03
Supernus Pharmaceuticals	USD 400.38M		21.13M	2022-03
Zoetis	USD 9.04B		3M	2026-03